About this event

  • Date and time Tue 20 Sep 2022 from 8:00am to 6:00pm
  • Location Royal Society of Medicine
  • Organised by Rheumatology and Rehabilitation

This event seeks to provide a detailed background into the field of autoimmune rheumatic diseases enabling participants to appreciate advances made in the past 40 years and the role and contribution Professor David Isenberg and his colleagues have made.

Join us to recognise the contribution Professor David Isenberg and colleagues have made to academic rheumatology in the past 40 years. Attendees will gain insight into the clinical features and outcomes of autoimmune rheumatic diseases (ARD).

This is an opportunity to learn more about the pathogenesis of ARDs and how a better understanding has led to better treatments and outcomes.

During this event, attendees will be able to:

  • Learn optimal methods of clinical assessment in the autoimmune rheumatic disease
  • Gain a better understanding of the current knowledge of immunopathology
  • Identify advances in therapy that have been made in the next decade

Follow us on: 

Facebook
Instagram
LinkedIn
Twitter
YouTube

Tickets

Early bird pricing available until 07 August 2022.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£45.00 £22.00 £22.00 £22.00 £15.00

Non - Member

Consultant / GP Non Healthcare Professional Trainee AHP / Nurse / Midwife Student
£60.00 £30.00 £30.00 £25.00 £20.00

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Professor David Isenberg 

Session 1

Chairs: Professor Peter Lydyard and Dr Debajit Sen, Consultant Paediatric, Adolescent and Adult Rheumatologist, University College London Hospitals NHS Foundation Trust and Honorary Clinical Professor, Division of Medicine, University College London 

Long term outcomes in the University College London Hospitals lupus cohort

Professor Anisur Rahman, Professor of Rheumatology, University College London Hospitals NHS Foundation Trust

Memories of myositis

Professor Jo Cambridge

Muscle, music and matches

Professor Mike Hanna

David and Fred’s excellent adventures in myositis

Professor Fred Miller

Developing obstetric rheumatology: From here to maternity

Professor Ian Giles, Professor of Rheumatology, Centre for Rheumatology Research, University College London

DOACs and APS: Back to the future

Professor Hannah Cohen

Tea and coffee break

Session 2

Chairs: Professor John Morrow, Human Microbiome Centre, King’s College London and Professor Pat Woo, Professor Pat Woo, Emeritus Professor, Paediatric Rheumatology, University College London

What have fats got to do with it?

Professor Liz Jury

Making a song and dance about steroids

Professor Liz Lightstone

B cell depletion therapy: past, present and future

Dr Ed Vital, Associate Professor, School of Medicine, University of Leeds

Advancing knowledge in SLE: The game is about glory

Professor Ian Bruce

Clinical coronary artery disease in SLE: Newer concepts

Professor Murray Urowitz, Professor of Medicine, University of Toronto

Lupus: Tracking the butterfly and the wolf

Professor Caroline Gordon, Emeritus Professor of Rheumatology, University of Birmingham

Lunch

Session 3

Chairs: Professor Peter Maddison and Dr Michael Snaith

David and the adolescent journey

Professor Lucy Wedderburn

The ABC of lupus: Antibodies, brains and colleagues

Professor Betty Diamond, Professor, Feinstein Institutes for Medical Research

Cognitive dysfunction in SLE: Single-center cohort presentation

Dr Raquel Faria

To: David Isenberg From: The SLICCest view

Dr Rosalind Ramsey-Goldman

Exeunt lupus, Sjögren’s, MCTD: Has the time come for a  new taxonomy?

Professor Ronald Van Vollenhoven, Professor and Chair, Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers and  Director, Amsterdam Rheumatology Center, Netherlands

Tea and coffee break

Session 4

Dr Isenberg I presume: A chance meeting in the jungle of lupus trials

Dr Joan Merrill, Professor of Medicine, Oklahoma Medical Research Foundation, University of Oklahoma

Natural autoantibodies to type-I interferons normalize blood IFNa and B cell subsets abnormality in lupus patients

Professor Claudia Mauri

Solar power: The sun and lupus

Dr Keith Elkon

Can 'Haifa Road' be a substitute for Abbey Road?

Professor Alexandra Balbir-Gurman, Director, Rheumatology Institute, Ramjbam Health Care Campus

Advances in the treatment of rheumatoid arthritis - the next 50 years

Professor John Isaacs, Professor of Clinical Rheumatology, Newcastle University and Associate Medical Director, Research, Newcastle upon Tyne Hospitals NHS Foundation Trust

Lupus in Africa: A unicorn?

Dr Dzifa Dey, Senior Lecturer, University of Ghana Medical School and Consultant Rheumatologist, Korlebu Teaching Hospital, Accra, Ghana

Back to the future: When this baby hits autoantibodies you are going to see some serious (SLE)DAI

Professor Michael Ehrenstein, Professor of Experimental Rheumatology, University College London and Honorary Consultant Rheumatologist, University College London Hospitals NHS Foundation Trust

Closing remarks

Professor David Isenberg

Close of meeting
Drinks reception

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom